Entity Common Stock, Shares Outstanding of ENANTA PHARMACEUTICALS INC from 10 May 2013 to 05 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ENANTA PHARMACEUTICALS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 May 2013 to 05 Feb 2026.
  • ENANTA PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding for the quarter ending 05 Feb 2026 was 29,019,344, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 29,019,344 +7,686,800 +36% 05 Feb 2026 10-Q 11 Feb 2026 2026 Q1
Q3 2025 28,862,601 +7,668,275 +36% 04 Nov 2025 10-K 19 Nov 2025 2025 FY
Q2 2025 21,377,923 +189,352 +0.89% 05 Aug 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 21,376,581 +197,181 +0.93% 01 May 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 21,332,544 +176,561 +0.84% 04 Feb 2025 10-Q 12 Feb 2025 2024 Q1
Q3 2024 21,194,326 +135,401 +0.64% 05 Nov 2024 10-K 27 Nov 2024 2024 FY
Q2 2024 21,188,571 +133,179 +0.63% 05 Aug 2024 10-Q 07 Aug 2024 2024 Q3
Q1 2024 21,179,400 +124,008 +0.59% 30 Apr 2024 10-Q 08 May 2024 2024 Q2
Q4 2023 21,155,983 +269,550 +1.3% 31 Jan 2024 10-Q 08 Feb 2024 2024 Q1
Q3 2023 21,058,925 +261,434 +1.3% 01 Nov 2023 10-K 22 Nov 2023 2023 FY
Q2 2023 21,055,392 +330,524 +1.6% 01 Aug 2023 10-Q 08 Aug 2023 2023 Q3
Q1 2023 21,055,392 +342,701 +1.7% 28 Apr 2023 10-Q 09 May 2023 2023 Q2
Q4 2022 20,886,433 +356,348 +1.7% 31 Jan 2023 10-Q 08 Feb 2023 2023 Q1
Q3 2022 20,797,491 +472,696 +2.3% 01 Nov 2022 10-K 23 Nov 2022 2022 FY
Q2 2022 20,724,868 +510,018 +2.5% 02 Aug 2022 10-Q 08 Aug 2022 2022 Q3
Q1 2022 20,712,691 +517,562 +2.6% 27 Apr 2022 10-Q 09 May 2022 2022 Q2
Q4 2021 20,530,085 +358,233 +1.8% 31 Jan 2022 10-Q 10 Feb 2022 2022 Q1
Q3 2021 20,324,795 +245,853 +1.2% 01 Nov 2021 10-K 24 Nov 2021 2021 FY
Q2 2021 20,214,850 +142,706 +0.71% 29 Jul 2021 10-Q 09 Aug 2021 2021 Q3
Q1 2021 20,195,129 +190,871 +0.95% 26 Apr 2021 10-Q 10 May 2021 2021 Q2
Q4 2020 20,171,852 +247,426 +1.2% 31 Jan 2021 10-Q 09 Feb 2021 2021 Q1
Q3 2020 20,078,942 +353,437 +1.8% 01 Nov 2020 10-K 25 Nov 2020 2020 FY
Q2 2020 20,072,144 +390,535 +2% 30 Jul 2020 10-Q 10 Aug 2020 2020 Q3
Q1 2020 20,004,258 +334,532 +1.7% 30 Apr 2020 10-Q 11 May 2020 2020 Q2
Q4 2019 19,924,426 +482,842 +2.5% 31 Jan 2020 10-Q 10 Feb 2020 2020 Q1
Q3 2019 19,725,505 +301,556 +1.6% 01 Nov 2019 10-K 27 Nov 2019 2019 FY
Q2 2019 19,681,609 +304,082 +1.6% 30 Jul 2019 10-Q 09 Aug 2019 2019 Q3
Q1 2019 19,669,726 +402,127 +2.1% 28 Apr 2019 10-Q 10 May 2019 2019 Q2
Q4 2018 19,441,584 +315,578 +1.6% 31 Jan 2019 10-Q 08 Feb 2019 2019 Q1
Q3 2018 19,423,949 01 Nov 2018 10-K 29 Nov 2018 2018 FY
Q2 2018 19,377,527 +287,144 +1.5% 01 Aug 2018 10-Q 09 Aug 2018 2018 Q3
Q1 2018 19,267,599 +184,088 +0.96% 01 May 2018 10-Q 10 May 2018 2018 Q2
Q4 2017 19,126,006 +87,079 +0.46% 01 Dec 2017 10-K 11 Dec 2017 2017 FY
Q2 2017 19,090,383 +54,473 +0.29% 01 Aug 2017 10-Q 09 Aug 2017 2017 Q3
Q1 2017 19,083,511 +126,278 +0.67% 01 May 2017 10-Q 10 May 2017 2017 Q2
Q4 2016 19,038,927 +113,616 +0.6% 01 Dec 2016 10-K 09 Dec 2016 2016 FY
Q2 2016 19,035,910 +321,934 +1.7% 01 Aug 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 18,957,233 +265,207 +1.4% 01 May 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 18,925,311 +244,897 +1.3% 31 Jan 2016 10-Q 09 Feb 2016 2016 Q1
Q2 2015 18,713,976 +131,348 +0.71% 31 Jul 2015 10-Q 10 Aug 2015 2015 Q3
Q1 2015 18,692,026 +154,182 +0.83% 30 Apr 2015 10-Q 08 May 2015 2015 Q2
Q4 2014 18,680,414 +718,701 +4% 30 Jan 2015 10-Q 06 Feb 2015 2015 Q1
Q2 2014 18,582,628 +670,954 +3.7% 08 Aug 2014 10-Q 12 Aug 2014 2014 Q3
Q1 2014 18,537,844 +719,048 +4% 09 May 2014 10-Q 12 May 2014 2014 Q2
Q4 2013 17,961,713 16 Dec 2013 10-K 18 Dec 2013 2013 FY
Q2 2013 17,911,674 09 Aug 2013 10-Q 12 Aug 2013 2013 Q3
Q1 2013 17,818,796 10 May 2013 10-Q 15 May 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.